CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

OXGN's EPS from Cont. Operations Growth by Quarter and Year

Mateon Therapeutics Inc's EPS from Cont. Operations results by quarter and year




OXGN EPS from Cont. Operations (in $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -0.06 -0.02 -0.15
III Quarter September - -0.01 -0.03 -0.15
II Quarter June 0.01 -0.02 -0.09 -0.12
I Quarter March -0.05 -0.02 -0.13 -0.14
FY   -0.04 -0.11 -0.27 -0.56



OXGN EPS from Cont. Operations second quarter 2020 Y/Y Growth Comment
Mateon Therapeutics Inc in the second quarter achieved EPS from Cont. Operations of $ 0.01 compare to EPS loss from Cont. Operations recorded in same quarter a year ago.

According to the results reported in the second quarter, Mateon Therapeutics Inc achieved the best EPS from Cont. Operations growth in Biotechnology & Drugs industry. While Mateon Therapeutics Inc' s EPS from Cont. Operations no change of % ranks overall at the positon no. 0 in the second quarter.




OXGN EPS from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Mateon Therapeutics Inc's second quarter 2020 EPS from Cont. Operations $ 0.01 OXGN's Income Statement
Mateon Therapeutics Inc's second quarter 2019 EPS from Cont. Operations $ -0.02 Quarterly OXGN's Income Statement
New: More OXGN's historic EPS from Cont. Operations Growth >>


OXGN EPS from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Mateon Therapeutics Inc's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's II. Quarter Q/Q EPS from Cont. Operations Comment
This reversal of fortune II. Quarter 2020where Mateon Therapeutics Inc published EPS from Cont. Operations of $ 0.01 could be considered as a inception of positive business climet.Mateon Therapeutics Inc announced in the II. Quarter 2020 EPS from Cont. Operations of $ 0.01 compare to EPS loss from Cont. Operations recorded in previos quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential EPS from Cont. Operations growth. While Mateon Therapeutics Inc's EPS from Cont. Operations growth quarter on quarter, overall rank is 0.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's II. Quarter Q/Q EPS from Cont. Operations Comment
This reversal of fortune II. Quarter 2020where Mateon Therapeutics Inc published EPS from Cont. Operations of $ 0.01 may is beginning of positive performance.Mateon Therapeutics Inc announced in the II. Quarter 2020 EPS from Cont. Operations of $ 0.01 compare to EPS loss from Cont. Operations recorded in previos quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential EPS from Cont. Operations growth. While Mateon Therapeutics Inc's EPS from Cont. Operations growth quarter on quarter, overall rank is 0.


Mateon Therapeutics Inc's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
Cumulative EPS from Cont. Operations 12 Months Ending $ -0.11 $ -0.14 $ -0.11 $ -0.07 $ -0.09
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment
Mateon Therapeutics Inc' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -0 in the Jun 30 2020 period.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment
Mateon Therapeutics Inc' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -0 in the Jun 30 2020 period.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Biotechnology & Drugs Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
OXGN's EPS from Cont. Operations Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for OXGN's Competitors
EPS from Cont. Operations Growth for Mateon Therapeutics Inc's Suppliers
EPS from Cont. Operations Growth for OXGN's Customers

You may also want to know
OXGN's Annual Growth Rates OXGN's Profitability Ratios OXGN's Asset Turnover Ratio OXGN's Dividend Growth
OXGN's Roe OXGN's Valuation Ratios OXGN's Financial Strength Ratios OXGN's Dividend Payout Ratio
OXGN's Roa OXGN's Inventory Turnover Ratio OXGN's Growth Rates OXGN's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Jun 30 2020 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Jun 30 2020
Lifevantage Corp -6.68 %$ -6.675 
Quest Diagnostics Inc -9.21 %$ -9.211 
Msa Safety Inc -9.71 %$ -9.709 
Atrion Corporation -9.98 %$ -9.981 
Medpace Holdings inc -10.53 %$ -10.526 
Amgen Inc -14.48 %$ -14.485 
Acadia Healthcare Company Inc -14.55 %$ -14.545 
Icu Medical Inc -18.02 %$ -18.018 
Catalyst Pharmaceuticals Inc -18.18 %$ -18.182 
Lemaitre Vascular Inc -26.09 %$ -26.087 
Vanda Pharmaceuticals Inc -27.27 %$ -27.273 
Baxter International Inc -28.36 %$ -28.358 
Bruker Corporation -30.43 %$ -30.435 
Pfizer Inc -31.87 %$ -31.868 
Johnson and Johnson -34.60 %$ -34.597 
Phibro Animal Health Corp -35.90 %$ -35.901 
Becton Dickinson And Company -35.95 %$ -35.948 
Abbott Laboratories -47.37 %$ -47.368 
United Therapeutics Corporation -48.08 %$ -48.077 
Abiomed Inc -49.75 %$ -49.746 
China Health Industries Holdings Inc -52.54 %$ -52.544 
Neurotrope inc -58.06 %$ -58.065 
Jrsis Health Care Corp -60.29 %$ -60.295 
Semler Scientific Inc -60.98 %$ -60.976 
Utah Medical Products Inc -62.11 %$ -62.105 
Encompass Health Corporation -63.44 %$ -63.441 
Syneos Health Inc -63.64 %$ -63.636 
Biotelemetry Inc -72.00 %$ -72.000 
Inogen Inc -74.47 %$ -74.468 
Intuitive Surgical Inc -78.99 %$ -78.986 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SRGZ's Profile

Stock Price

SRGZ's Financials

Business Description

Fundamentals

Charts & Quotes

SRGZ's News

Suppliers

SRGZ's Competitors

Customers & Markets

Economic Indicators

SRGZ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071